Please login to the form below

Not currently logged in
Email:
Password:

talimogene laherparepvec

This page shows the latest talimogene laherparepvec news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Amgen's T-Vec for melanoma

FDA panel backs Amgen's T-Vec for melanoma

The panel voted 22 to one in favour of approving T-Vec (talimogene laherparepvec) on the strength of the phase III OPTiM study, which found that the response rate to the

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

Genetic Digital provides strategically driven digital solutions for healthcare, pharma & life sciences brands so they can optimise their web...

Latest intelligence

How do you solve a problem like non-adherence? Part 1
Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...
How to design patient services with social media within the ABPI code guidelines
In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services....
Infographic: PsO market snapshot
...

Infographics